Related references
Note: Only part of the references are listed.Models of psychedelic drug action: modulation of cortical-subcortical circuits
Manoj K. Doss et al.
BRAIN (2022)
Psychedelics and health behaviour change
Pedro J. Teixeira et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2022)
A neurobiological perspective on social influence: Serotonin and social adaptation
Patricia Duerler et al.
JOURNAL OF NEUROCHEMISTRY (2022)
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline
Danilo De Gregorio et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials
Jacob S. Aday et al.
PSYCHOPHARMACOLOGY (2022)
Psychopharmacology and Explanatory Pluralism
Awais Aftab et al.
JAMA PSYCHIATRY (2022)
Future directions for clinical psilocybin research: The relaxed symptom network.
Evan Lewis-Healey et al.
Psychology and Neuroscience (2022)
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies
Kristoffer A. A. Andersen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
Brief Sensory Deprivation Triggers Cell Type-Specific Structural and Functional Plasticity in Olfactory Bulb Neurons
Elisa Galliano et al.
JOURNAL OF NEUROSCIENCE (2021)
A non-hallucinogenic psychedelic analogue with therapeutic potential
Lindsay P. Cameron et al.
NATURE (2021)
MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens
Felix Mueller et al.
NEUROPSYCHOPHARMACOLOGY (2021)
The History of Psychedelics in Psychiatry
David E. Nichols et al.
PHARMACOPSYCHIATRY (2021)
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
Danilo De Gregorio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Psychedelics in Psychiatry-Keeping the Renaissance From Going Off the Rails
David B. Yaden et al.
JAMA PSYCHIATRY (2021)
Cognitive and behavioural flexibility: neural mechanisms and clinical considerations
Lucina Q. Uddin
NATURE REVIEWS NEUROSCIENCE (2021)
Self-blinding citizen science to explore psychedelic microdosing
Balazs Szigeti et al.
ELIFE (2021)
Psychedelics alter metaphysical beliefs
Christopher Timmermann et al.
SCIENTIFIC REPORTS (2021)
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
Manoj K. Doss et al.
TRANSLATIONAL PSYCHIATRY (2021)
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
H. Kettner et al.
FRONTIERS IN PHARMACOLOGY (2021)
Set and Setting in the Santo Daime
Ido Hartogsohn
FRONTIERS IN PHARMACOLOGY (2021)
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Ling-Xiao Shao et al.
NEURON (2021)
From many to (n)one: Meditation and the plasticity of the predictive mind
Ruben E. Laukkonen et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
Friederike Holze et al.
FRONTIERS IN PHARMACOLOGY (2021)
Working with Weirdness: A Response to Moving Past Mysticism in Psychedelic Science
Joost J. Breeksema et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
Nadia R. P. W. Hutten et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine
Matthew W. Johnson
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice
Jake E. Payne et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Bio-psycho-social interaction: an enactive perspective
Sanneke de Haan
INTERNATIONAL REVIEW OF PSYCHIATRY (2021)
LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making
Thomas Pokorny et al.
PSYCHOLOGICAL MEDICINE (2020)
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings
Matthias Forstmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Tripping on nothing: placebo psychedelics and contextual factors
Jay A. Olson et al.
PSYCHOPHARMACOLOGY (2020)
Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism
Valerie van Mulukom et al.
PSYCHOPHARMACOLOGY (2020)
Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects
Alan K. Davis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
The claustrum coordinates cortical slow-wave activity
Kimiya Narikiyo et al.
NATURE NEUROSCIENCE (2020)
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
Frederick S. Barrett et al.
NEUROIMAGE (2020)
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
N. L. Mason et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kuglae Kim et al.
CELL (2020)
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review
Genis Ona et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Mystical and Other Alterations in Sense of Self: An Expanded Framework for Studying Nonordinary Experiences
Ann Taves
PERSPECTIVES ON PSYCHOLOGICAL SCIENCE (2020)
Psychedelic Microdosing: Prevalence and Subjective Effects
Lindsay P. Cameron et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2020)
The use of the psychological flexibility model to support psychedelic assisted therapy
Rosalind Watts et al.
JOURNAL OF CONTEXTUAL BEHAVIORAL SCIENCE (2020)
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety
Alan K. Davis et al.
JOURNAL OF CONTEXTUAL BEHAVIORAL SCIENCE (2020)
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
Martin K. Madsen et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Effective connectivity changes in LSD-induced altered states of consciousness in humans
Katrin H. Preller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Oxytocin-dependent reopening of a social reward learning critical period with MDMA
Romain Nardou et al.
NATURE (2019)
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Leor Roseman et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
Kim P. C. Kuypers et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
R. L. Carhart-Harris et al.
PHARMACOLOGICAL REVIEWS (2019)
Resting state functional connectivity and cognitive task-related activation of the human claustrum
Samuel R. Krimmel et al.
NEUROIMAGE (2019)
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
Lukasz Smigielski et al.
NEUROIMAGE (2019)
Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat
Lukasz Smigielski et al.
SCIENTIFIC REPORTS (2019)
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
Matthew W. Johnson et al.
PHARMACOLOGY & THERAPEUTICS (2019)
nStudying the experience of meditation through Micro-phenomenology
Claire Petitmengin et al.
CURRENT OPINION IN PSYCHOLOGY (2019)
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
Raissa Nobrega de Almeida et al.
FRONTIERS IN PSYCHOLOGY (2019)
Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being
Natasha L. Mason et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2019)
The development of the Awe Experience Scale (AWE-S): A multifactorial measure for a complex emotion
David B. Yaden et al.
JOURNAL OF POSITIVE PSYCHOLOGY (2019)
Psychedelics as a treatment for disorders of consciousness
Gregory Scott et al.
NEUROSCIENCE OF CONSCIOUSNESS (2019)
The role of alcohol in expectancy-driven mystical experiences: a pre-registered field study using placebo brain stimulation
David L. R. Maij et al.
RELIGION BRAIN & BEHAVIOR (2019)
Causation in Mixed Methods Research: The Meeting of Philosophy, Science, and Practice
R. Burke Johnson et al.
JOURNAL OF MIXED METHODS RESEARCH (2019)
Absorption and spiritual experience: A review of evidence and potential mechanisms
Michael Lifshitz et al.
CONSCIOUSNESS AND COGNITION (2019)
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Psychiatry & the psychedelic drugs. Past, present & future
James J. H. Rucker et al.
NEUROPHARMACOLOGY (2018)
MDMA Impairs Both the Encoding and Retrieval of Emotional Recollections
Manoj K. Doss et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Acute LSD effects on response inhibition neural networks
A. Schmidt et al.
PSYCHOLOGICAL MEDICINE (2018)
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences
Theresa M. Carbonaro et al.
PSYCHOPHARMACOLOGY (2018)
The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant
Ben Sessa
PSYCHOPHARMACOLOGY (2018)
Psychedelics and connectedness
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
The Predictive Coding Account of Psychosis
Philipp Sterzer et al.
BIOLOGICAL PSYCHIATRY (2018)
Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression
Taylor Lyons et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
The entropic brain - revisited
Robin L. Carhart-Harris
NEUROPHARMACOLOGY (2018)
Serotonergic psychedelics and personality: A systematic review of contemporary research
Jose Carlos Bouso et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics
Emmanuelle A. D. Schindler et al.
FRONTIERS IN PHARMACOLOGY (2018)
Claustrum circuit components for top-down input processing and cortical broadcast
Michael G. White et al.
BRAIN STRUCTURE & FUNCTION (2018)
The Claustrum Supports Resilience to Distraction
Gal Atlan et al.
CURRENT BIOLOGY (2018)
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition
Frederick S. Barrett et al.
PSYCHOPHARMACOLOGY (2018)
Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
Luisa Prochazkova et al.
PSYCHOPHARMACOLOGY (2018)
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
Katrin H. Preller et al.
ELIFE (2018)
The Nondual Awareness Dimensional Assessment (NADA): New Tools to Assess Nondual Traits and States of Consciousness Occurring Within and Beyond the Context of Meditation
Adam W. Hanley et al.
PSYCHOLOGICAL ASSESSMENT (2018)
Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy
Peter S. Hendricks
INTERNATIONAL REVIEW OF PSYCHIATRY (2018)
Psychedelics as Medicines: An Emerging New Paradigm
D. E. Nichols et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Cortical Hierarchy Governs Rat Claustrocortical Circuit Organization
Michael G. White et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2017)
Long-term follow-up of psilocybin-facilitated smoking cessation
Matthew W. Johnson et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2017)
Effect of Psilocybin on Empathy and Moral Decision-Making
Thomas Pokorny et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness
Matthias Forstmann et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
The social transmission of metacontrol policies: Mechanisms underlying the interpersonal transfer of persistence and flexibility
Bernhard Hommel et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Psychedelic Drugs in Biomedicine
Evan J. Kyzar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
Michael M. Schartner et al.
SCIENTIFIC REPORTS (2017)
Self unbound: ego dissolution in psychedelic experience
Chris Letheby et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Toward a Functional View of the p Factor in Psychopathology
Charles S. Carver et al.
CLINICAL PSYCHOLOGICAL SCIENCE (2017)
Neuroticism is associated with challenging experiences with psilocybin mushrooms
Frederick S. Barrett et al.
PERSONALITY AND INDIVIDUAL DIFFERENCES (2017)
The Dark Side of the Sublime: Distinguishing a Threat-Based Variant of Awe
Amie M. Gordon et al.
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY (2017)
Of Roots and Fruits: A Comparison of Psychedelic and Nonpsychedelic Mystical Experiences
David B. Yaden et al.
JOURNAL OF HUMANISTIC PSYCHOLOGY (2017)
The Varieties of Self-Transcendent Experience
David Bryce Yaden et al.
REVIEW OF GENERAL PSYCHOLOGY (2017)
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller et al.
CURRENT BIOLOGY (2017)
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities
Joaquim Soler et al.
PSYCHOPHARMACOLOGY (2016)
Attention alters predictive processing
Andy Clark
BEHAVIORAL AND BRAIN SCIENCES (2016)
Oxytocin Conditions Intergroup Relations Through Upregulated In-Group Empathy, Cooperation, Conformity, and Defense
Carsten K. W. De Dreu et al.
BIOLOGICAL PSYCHIATRY (2016)
Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution
Enzo Tagliazucchi et al.
CURRENT BIOLOGY (2016)
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
Thomas Pokorny et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)
Matthew M. Nour et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2016)
LSD-Induced Entropic Brain Activity Predicts Subsequent Personality Change
A. V. Lebedev et al.
HUMAN BRAIN MAPPING (2016)
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Theresa M. Carbonaro et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
Ido Hartogsohn
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Thalamus plays a central role in ongoing cortical functioning
S. Murray Sherman
NATURE NEUROSCIENCE (2016)
A placebo-controlled investigation of synaesthesia-like experiences under LSD
Devin B. Terhune et al.
NEUROPSYCHOLOGIA (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors
Danilo De Gregorio et al.
PHARMACOLOGICAL RESEARCH (2016)
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
K. P. C. Kuypers et al.
PSYCHOPHARMACOLOGY (2016)
The Language of Ineffability: Linguistic Analysis of Mystical Experiences
David B. Yaden et al.
PSYCHOLOGY OF RELIGION AND SPIRITUALITY (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
The Brain's Default Mode Network
Marcus E. Raichle
ANNUAL REVIEW OF NEUROSCIENCE, VOL 38 (2015)
Neural substrates of cognitive flexibility in cocaine and gambling addictions
Antonio Verdejo-Garcia et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Registered Reports: Realigning incentives in scientific publishing
Christopher D. Chambers et al.
CORTEX (2015)
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
Tomislav Majic et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk
Alan Anticevic et al.
JAMA PSYCHIATRY (2015)
LSD enhances suggestibility in healthy volunteers
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2015)
Empathy and compassion
Tania Singer et al.
CURRENT BIOLOGY (2014)
Pheno-phenotypes: a holistic approach to the psychopathology of schizophrenia
Giovanni Stanghellini et al.
CURRENT OPINION IN PSYCHIATRY (2014)
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
Robin L. Carhart-Harris et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2014)
Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing
Matthew G. Kirkpatrick et al.
NEUROPSYCHOPHARMACOLOGY (2014)
No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT1a Receptor Activation
Kim P. C. Kuypers et al.
PLOS ONE (2014)
Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans
Matthew G. Kirkpatrick et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Ketamine administration in depressive disorders: a systematic review and meta-analysis
Guillaume Fond et al.
PSYCHOPHARMACOLOGY (2014)
The claustrum in review
Brian N. Mathur
FRONTIERS IN SYSTEMS NEUROSCIENCE (2014)
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
David Baumeister et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)
The p Factor: One General Psychopathology Factor in the Structure of Psychiatric Disorders?
Avshalom Caspi et al.
CLINICAL PSYCHOLOGICAL SCIENCE (2014)
Network Analysis: An Integrative Approach to the Structure of Psychopathology
Denny Borsboom et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 9 (2013)
Whatever next? Predictive brains, situated agents, and the future of cognitive science
Andy Clark
BEHAVIORAL AND BRAIN SCIENCES (2013)
The Amsterdam Resting-State Questionnaire reveals multiple phenotypes of resting-state cognition
B. Alexander Diaz et al.
Frontiers in Human Neuroscience (2013)
Broadband Cortical Desynchronization Underlies the Human Psychedelic State
Suresh D. Muthukumaraswamy et al.
JOURNAL OF NEUROSCIENCE (2013)
Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users
Jose Carlos Bouso et al.
PSYCHOPHARMACOLOGY (2013)
Oxytocin modulates cooperation within and competition between groups: An integrative review and research agenda
Carsten K. W. De Dreu
HORMONES AND BEHAVIOR (2012)
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Teri S. Krebs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
Boris B. Quednow et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
Visual Trails: Do the Doors of Perception Open Periodically?
Julien Dubois et al.
PLOS BIOLOGY (2011)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
Erich Studerus et al.
PLOS ONE (2010)
Predictive coding under the free-energy principle
Karl J. Friston et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2009)
Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis
Joerg Daumann et al.
PSYCHOPHARMACOLOGY (2008)
Serotonin research: contributions to understanding psychoses
Mark A. Geyer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action
Danuta Marona-Lewicka et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval
Franz X. Vollenweider et al.
NEUROPSYCHOPHARMACOLOGY (2007)
A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4-methylenedioxymethamphetamine (ecstasy)
M. R. Thompson et al.
NEUROSCIENCE (2007)
Effects of psilocybin on time perception and temporal control of behaviour in humans
Marc Wittmann et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis
E Gouzoulis-Mayfrank et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors
OL Carter et al.
JOURNAL OF COGNITIVE NEUROSCIENCE (2005)
The Penn Conditional Exclusion Test: a new measure of executive-function with alternate forms for repeat administration
MM Kurtz et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2004)
Approaching awe, a moral, spiritual, and aesthetic emotion
D Keltner et al.
COGNITION & EMOTION (2003)
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans
M Wichers et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain
CD Nichols et al.
NEUROPSYCHOPHARMACOLOGY (2002)
A systems model of altered consciousness: Integrating natural and drug-induced psychoses
FX Vollenweider et al.
BRAIN RESEARCH BULLETIN (2001)
Diffusion tensor imaging: Concepts and applications
D Le Bihan et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2001)
The Jefferson Scale of Physician Empathy: Development and preliminary psychometric data
M Hojat et al.
EDUCATIONAL AND PSYCHOLOGICAL MEASUREMENT (2001)